Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$483K Buy
4,715
+750
+19% +$76.4K ﹤0.01% 1033
2025
Q4
$399K Buy
3,965
+585
+17% +$57.7K ﹤0.01% 1041
2025
Q3
$292K Buy
3,380
+34
+1% +$2.69K ﹤0.01% 1171
2025
Q2
$255K Buy
+3,346
New +$245K ﹤0.01% 1212
2024
Q4
Sell
-2,243
Closed -$229K 1460
2024
Q3
$229K Buy
+2,243
New +$186K ﹤0.01% 1187

Other funds holding NUVL

Xponance's NUVL Position: Q1 2026 in Review

Xponance increased its Nuvalent (NUVL) stake by 19% in Q1 2026, buying an estimated $76.4K and bringing the position to 4,715 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Xponance first reported a position in NUVL in Q3 2024 and has held it in 5 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Xponance held 4,715 shares of Nuvalent worth $483K as of Q1 2026.
  • Xponance bought 750 Nuvalent shares in Q1 2026, an estimated $76.4K.
  • Nuvalent made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1033 holding.
  • Xponance first reported a position in Nuvalent in Q3 2024 and has held it in 5 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.